Such derivatives showed single-digit nanomolar potency against LSD1 joined to high selectivity over MAOs, and single-digit micromolar (or lower) IC50 values against a panel of leukemia cells (MV4-11, THP-1, and NB4) (Vianello et al., 2017). The gene discussed is KDM1A; the disease is leukemia.